NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Akebia Therapeutics Inc (NASDAQ: AKBA)

 
AKBA Technical Analysis
5
As on 5th Aug 2022 AKBA SHARE Price closed @ 0.40 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.00 & Strong Sell for SHORT-TERM with Stoploss of 3.32 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AKBASHARE Price

Open 0.40 Change Price %
High 0.41 1 Day -0.01 -2.44
Low 0.39 1 Week -0.01 -2.44
Close 0.40 1 Month 0.01 2.56
Volume 6756200 1 Year -3.71 -90.27
52 Week High 4.44 | 52 Week Low 0.32
 
NASDAQ USA Most Active Stocks
AMD 102.31 -1.54%
MRKR 0.54 63.64%
DKNG 17.96 9.78%
AAPL 165.35 -0.28%
OPEN 5.72 21.70%
BBBY 8.16 32.68%
AMZN 140.80 -1.24%
LYFT 20.28 16.62%
GOVX 3.22 -9.80%
ENDP 0.72 12.50%
 
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
USWS 5.60 508.70%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
GPCOR 0.15 114.29%
GSMGW 0.02 100.00%
FTVIW 0.22 83.33%
GBRGR 0.12 71.43%
PTOCW 0.17 70.00%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
CREXW 0.04 -55.56%
MILEW 0.06 -53.85%
HSDT 0.48 -52.94%
BTAQW 0.01 -50.00%
ALACW 0.01 -50.00%
HYZNW 0.37 -49.32%
ACBAW 0.08 -46.67%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
 
 
AKBA
Daily Charts
AKBA
Intraday Charts
Whats New @
Bazaartrend
AKBA
Free Analysis
 
AKBA Important Levels Intraday
RESISTANCE0.44
RESISTANCE0.43
RESISTANCE0.42
RESISTANCE0.41
SUPPORT0.39
SUPPORT0.38
SUPPORT0.37
SUPPORT0.36
 
AKBA Forecast August 2022
4th UP Forecast2.06
3rd UP Forecast1.53
2nd UP Forecast1.2
1st UP Forecast0.87
1st DOWN Forecast-0.07
2nd DOWN Forecast-0.4
3rd DOWN Forecast-0.73
4th DOWN Forecast-1.26
 
AKBA Weekly Forecast
4th UP Forecast2.87
3rd UP Forecast2.08
2nd UP Forecast1.59
1st UP Forecast1.10
1st DOWN Forecast-0.30
2nd DOWN Forecast-0.79
3rd DOWN Forecast-1.28
4th DOWN Forecast-2.07
 
AKBA Forecast2022
4th UP Forecast8.17
3rd UP Forecast5.68
2nd UP Forecast4.14
1st UP Forecast2.6
1st DOWN Forecast-1.8
2nd DOWN Forecast-3.34
3rd DOWN Forecast-4.88
4th DOWN Forecast-7.37
 
 
AKBA Other Details
Segment EQ
Market Capital 495685056.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
AKBA Address
AKBA
 
AKBA Latest News
 
Your Comments and Response on Akebia Therapeutics Inc
 
AKBA Business Profile
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Address: 245 First Street, Cambridge, MA, United States, 02142
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service